Supply chain problems Pfizer can halve the supply of vaccines by 2020

ON December 3, local time, Pfizer said it would deliver only half the promised dose of the new crown vaccine by the end of 2020, reducing its planned global rollout from 100 million doses to 50 million doses, Chinese reported.
reported that Pfizer had to scale back its plans because of a slowdown in its supply chain.
company's spokesman said, "Expanding the raw material supply chain has been longer than expected."
" also said that expanding vaccine production at this rate was unprecedented, but that progress was being made.
Pfizer's shares fell 1.74 percent after the announcement.
reported that Pfizer's vaccine was provisionally approved by UK regulators on December 2nd and is expected to be approved for emergency use by the US Food and Drug Administration after a meeting on December 10.
the U.S. new crown vaccine program, Curve Acceleration, had planned to receive 40 million doses of the vaccine from Pfizer and Modner by the end of 2020.
now, the U.S. could get only 10 million doses of Pfizer's vaccine, or just 5 million Americans.
the same type of technology as the new crown vaccine in the U.S., but the company has not reported supply chain problems, the company said in a statement.
, there are now more than 14 million confirmed cases in the United States and more than 275,000 deaths in the United States.
more than 2,800 new deaths in the US on December 3rd, another record high.
。